Bioequivalence assessment of pharmaceutical aerosol products through IVIVC

Role of CFD based in silico modelling in establishing an in vitro-in vivo correlation of aerosol deposition in the respiratory tract

(2020) Fen Huang et al.   ADVANCED DRUG DELIVERY REVIEWS

Evaluation of Bio-relevant Mouth-Throat Models for Characterization of Metered Dose Inhalers

(2019) Anubhav Kaviratna et al.   AAPS PHARMSCITECH

In Vitro Tests for Aerosol Deposition. VI: Realistic Testing with Different Mouth–Throat Models and In Vitro—In Vivo Correlations for a Dry Powder Inhaler, Metered Dose Inhaler, and Soft Mist Inhaler

(2018) Xiangyin Wei et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

Use of computational fluid dynamics deposition modeling in respiratory drug delivery

(2018) P. Worth Longest et al.   Expert Opinion on Drug Delivery

Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler

(2017) Rajoshi Biswas et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

Variability in Delivered Dose from Pressurized Metered-Dose Inhaler Formulations Due to a Delay Between Shake and Fire

(2017) Ross H.M. Hatley et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

In Vitro Tests for Aerosol Deposition. V: Using Realistic Testing to Estimate Variations in Aerosol Properties at the Trachea

(2017) Xiangyin Wei et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

Batch-to-batch pharmacokinetic variability confounds current bioequivalence regulations: A dry powder inhaler randomized clinical trial

(2016) E Burmeister Getz et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Between-Batch Pharmacokinetic Variability Inflates Type I Error Rate in Conventional Bioequivalence Trials: A Randomized Advair Diskus Clinical Trial

(2016) E Burmeister Getz et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World Conditions

(2015) Giorgio Walter Canonica et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

In Vitro–In VivoCorrelations Observed With Indacaterol-Based Formulations Delivered with the Breezhaler®

(2015) Jeffry G. Weers et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

Evaluation of the Transwell System for Characterization of Dissolution Behavior of Inhalation Drugs: Effects of Membrane and Surfactant

(2015) Marc Rohrschneider et al.   MOLECULAR PHARMACEUTICS

Optimization of an In Vitro Dissolution Test Method for Inhalation Formulations

(2015) Yoen-Ju Son et al.   DISSOLUTION TECHNOLOGIES

Validation of a General In Vitro Approach for Prediction of Total Lung Deposition in Healthy Adults for Pharmaceutical Inhalation Products

(2013) Bo Olsson et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

Dry Powder Inhalers: Study of the Parameters Influencing Adhesion and Dispersion of Fluticasone Propionate

(2012) V. N. P. Le et al.   AAPS PHARMSCITECH

In Vitro Tests for Aerosol Deposition. III: Effect of Inhaler Insertion Angle on Aerosol Deposition

(2012) Renish R. Delvadia et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

Comparison of Deposition in the USP and Physical Mouth–Throat Models with Solid and Liquid Particles

(2011) Yue Zhou et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

In Vitro Tests for Aerosol Deposition. I: Scaling a Physical Model of the Upper Airways to Predict Drug Deposition Variation in Normal Humans

(2011) Renishkumar R. Delvadia et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

In Vivo–In Vitro Correlations: Predicting Pulmonary Drug Deposition from Pharmaceutical Aerosols

(2010) Peter R. Byron et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

In Vitro Aqueous Fluid-Capacity-Limited Dissolution Testing of Respirable Aerosol Drug Particles Generated from Inhaler Products

(2010) Deepika Arora et al.   PHARMACEUTICAL RESEARCH

The Abbreviated Impactor Measurement (AIM) Concept: Part II—Influence of Evaporation of a Volatile Component—Evaluation with a “Droplet-Producing” Pressurized Metered Dose Inhaler (pMDI)-Based Formulation Containing Ethanol as Cosolvent

(2009) J. P. Mitchell et al.   AAPS PHARMSCITECH

The Abbreviated Impactor Measurement (AIM) Concept: Part 1—Influence of Particle Bounce and Re-Entrainment—Evaluation with a “Dry” Pressurized Metered Dose Inhaler (pMDI)-Based Formulation

(2009) J. P. Mitchell et al.   AAPS PHARMSCITECH

In Vitro/In Vivo Comparisons in Pulmonary Drug Delivery

(2008) Stephen P. Newman et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery